Clinical laboratories and healthcare providers as a whole received a number of welcome reprieves from potential payment cuts and burdensome regulation as 2022 drew to a close. But that doesn’t mean many of these issues couldn’t be resurrected in a different form in 2023.
From the ongoing workforce shortage to the elimination of the DEA X-Waiver, here are six recent developments we’ll be keeping an eye on this year.